Masiero Giulia, Arturi Federico, Soramio Elisa Boscolo, Fovino Luca Nai, Fabris Tommaso, Cardaioli Francesco, Panza Andrea, Lorenzoni Giulia, Napodano Massimo, Fraccaro Chiara, Tarantini Giuseppe
Interventional Cardiology Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua Medical School, Padova, Italy.
Unit of Biostatistics, Epidemiology and Public Health, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua Medical School, Padua, Italy.
Am J Cardiol. 2025 Jan 1;234:99-106. doi: 10.1016/j.amjcard.2024.11.010. Epub 2024 Nov 21.
Right-sided cardiac catheterization (RHC) is selectively recommended in mitral valve transcatheter edge-to-edge (M-TEER) workup because right ventricle (RV) hemodynamic parameters predict adverse outcomes. This study examines the impact of RV hemodynamics and the prognostic value of the 2022 European Society of Cardiology (ESC) pulmonary hypertension definitions on outcomes after M-TEER. Of 152 patients treated with M-TEER for symptomatic severe mitral regurgitation (MR) between December 2014 and February 2024 at our tertiary center, 71 underwent elective RHC before the procedure. The primary outcomes assessed were all-cause mortality and a composite of heart failure hospitalization and death at the longest available follow-up. In a cohort of 152 mostly male patients (64%) with a median age of 79 years who were treated for symptomatic severe MR, 71 underwent elective RHC. The causes were categorized as degenerative (47%), functional ventricular (41%), and atrial (12%). Pulmonary hypertension (PH) was common, with 74% showing mean pulmonary artery pressure (mPAP) >20 mm Hg and 39% with pulmonary vascular resistance (PVR) >2 Wood Units. Success rates were high, with technical, device, and procedural success at 97%, 88%, and 84%, respectively. At a median follow-up of 681 days, all-cause mortality was 50%, and the composite outcome (death or heart failure hospitalizations) occurred in 61%. Key hemodynamic parameters, including mPAP, PVR, and the tricuspid annular plane systolic excursion/systolic pulmonary artery pressure ratio, were independently linked to mortality risk. Kaplan-Meier analysis found significant associations with mPAP >20 mm Hg and pulmonary capillary wedge pressure >15 mm Hg for long-term mortality, whereas the 2022 ESC PH thresholds showed greater sensitivity, correlating with increased mortality risk. In patients with severe MR who undergo M-TEER, most RV invasive hemodynamic parameters are linked to adverse long-term outcomes, with mPAP, PVR, and the tricuspid annular plane systolic excursion/systolic pulmonary artery pressure ratio identified as independent predictors of mortality. Despite the study's limited sample size, the updated ESC PH definitions enhance prognostic assessment.
在二尖瓣经导管缘对缘修复术(M-TEER)评估中,选择性推荐进行右心导管检查(RHC),因为右心室(RV)血流动力学参数可预测不良预后。本研究探讨了RV血流动力学的影响以及2022年欧洲心脏病学会(ESC)肺动脉高压定义对M-TEER术后结局的预后价值。在2014年12月至2024年2月期间,我们的三级中心对152例因症状性严重二尖瓣反流(MR)接受M-TEER治疗的患者进行了研究,其中71例在手术前接受了选择性RHC。评估的主要结局是全因死亡率以及在最长随访期内心力衰竭住院和死亡的复合结局。在一组152例主要为男性(64%)、中位年龄79岁、因症状性严重MR接受治疗的患者中,71例接受了选择性RHC。病因分类为退行性(47%)、功能性心室(41%)和心房性(12%)。肺动脉高压(PH)很常见,74%的患者平均肺动脉压(mPAP)>20 mmHg,39%的患者肺血管阻力(PVR)>2 Wood单位。成功率很高,技术成功率、器械成功率和手术成功率分别为97%、88%和84%。在中位随访681天时,全因死亡率为50%,复合结局(死亡或心力衰竭住院)发生率为61%。关键血流动力学参数,包括mPAP、PVR和三尖瓣环平面收缩期位移/收缩期肺动脉压比值,与死亡风险独立相关。Kaplan-Meier分析发现,mPAP>20 mmHg和肺毛细血管楔压>15 mmHg与长期死亡率存在显著关联,而2022年ESC的PH阈值显示出更高的敏感性,与死亡风险增加相关。在接受M-TEER的严重MR患者中,大多数RV有创血流动力学参数与不良长期结局相关,mPAP、PVR和三尖瓣环平面收缩期位移/收缩期肺动脉压比值被确定为死亡率的独立预测因素。尽管该研究样本量有限,但更新后的ESC PH定义增强了预后评估。